ASCO’s 1st Quality Care Symposium

San Diego, CA—A real-time performance tracking system that monitors adherence to quality care metrics significantly improved adherence to quality standards over a 4-year period for 64 cancer centers participating in the Rapid Quality Reporting System (RQRS) “beta test,” according to researchers who are pioneering the program.

San Diego, CA—A multidisciplinary team approach for discussing end-of-life issues with patients reduces the use of the intensive care unit (ICU) without shortening survival time, researchers from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University said at ASCO’s inaugural 2012 Quality Care Symposium.

Cabozantinib (Cometriq; Exelixis) is the second drug ever to be approved by the FDA for the treatment of patients with metastatic medullary thyroid cancer.

San Diego, CA—Adherence to several quality care standards markedly improved in practices participating in ASCO’s Quality Oncology Practice Initiative (QOPI) over a 4-year period, according to a study presented at ASCO’s inaugural 2012 Quality Care Symposium.